미국의 퍼스널 모빌리티 디바이스 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 부문별 예측(2024-2030년)

U.S. Personal Mobility Devices Market Growth & Trends:

The U.S. personal mobility devices market size is anticipated to reach USD 5.9 billion by 2030, growing at a CAGR of 7.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The demand for personal mobility devices such as mobility scooters, power wheelchairs, and walkers is expected to increase due to the aging population, rising accidents causing disabilities, technological advancements, and new product developments. The market is mainly driven by the increasing prevalence of disabilities and chronic conditions among adults. According to the Centers for Disease Control and Prevention, around 27% of adults have a disability of some type in the United States.

One of the primary drivers is the growing aging population in the country. As people age, they tend to face mobility issues and require assistance in moving around. Personal mobility devices such as mobility scooters and power wheelchairs are crucial in helping them maintain their independence and mobility. Moreover, the increasing prevalence of chronic diseases such as arthritis, multiple sclerosis, and Parkinson's disease, which affect mobility, are fueling the market growth. Additionally, technological advancements and innovations in the industry have made personal mobility devices more efficient, comfortable, and safe, further fueling the market's growth.

For instance, in November 2023, Magic Mobility, a Sunrise Medical brand, launched the Magic 360, a stylish mid-wheel-drive crossover wheelchair in North America. It is equipped with interchangeable wheels and tires, all-wheel suspension, and a personalized seating system that caters to a variety of sizes and postural requirements. It is ideal for use in tight indoor spaces and can handle rough terrain outdoors.

U.S. Personal Mobility Devices Market Report Highlights:

• Wheelchairs dominated the product segment with more than 45.0% share in 2023, owing to the increasing prevalence of disabilities and chronic conditions, along with the growing aging population in the U.S.
• In April 2023, Medline partnered with Martha Stewart to launch a new line of stylish and practical safety and mobility products for the home. The Martha Stewart Custom Collection includes sophisticated prints and patterns, combining fashion with functionality to help users feel and look their best.
• In January 2021, Medline and byACRE, a Copenhagen-based designer of advanced mobility products, formed a strategic partnership to address the rising demand for stylish and functional mobility aids. As part of this collaboration, Medline was expected to be distributed byACRE's Carbon Ultralight rollator, recognized as the lightest rollator globally.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Products
  • 1.2.2. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Volume price analysis (Model 2)
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Personal Mobility Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Personal Mobility Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Personal Mobility Devices Market: Product Estimates & Trend Analysis

• 4.1. Form Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Personal Mobility Devices Market by Product Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Walking Aids
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (K Units) (USD Million)
    • 4.4.1.2. Rollators
    • 4.4.1.3. Market estimates and forecasts 2018 to 2030 (K Units) (USD Million)
    • 4.4.1.3.1. Premium Rollators
    • 4.4.1.3.1.1. Market estimates and forecasts 2018 to 2030 (K Units) (USD Million)
    • 4.4.1.3.2. Lo-Cost Rollators
    • 4.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (K Units) (USD Million)
    • 4.4.1.4. Others (Canes, Crutches and Walkers)
  • 4.4.2. Wheelchairs
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (K Units) (USD Million)
    • 4.4.2.2. Manual Wheelchairs
    • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (K Units) (USD Million)
    • 4.4.2.3. Powered Wheelchairs
    • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (K Units) (USD Million)
  • 4.4.3. Scooters
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (K Units) (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Recent Developments & Impact Analysis, By Key Market Participants
• 5.2. Company/Competition Categorization
• 5.3. Vendor Landscape
  • 5.3.1. List of key distributors and channel partners
  • 5.3.2. Key customers
  • 5.3.3. Key company heat map analysis, 2023
• 5.4. Company Profiles
  • 5.4.1. GF Health Products, Inc.
    • 5.4.1.1. Company overview
    • 5.4.1.2. Financial performance
    • 5.4.1.3. Product benchmarking
    • 5.4.1.4. Strategic initiatives
  • 5.4.2. Invacare Corporation
    • 5.4.2.1. Company overview
    • 5.4.2.2. Financial performance
    • 5.4.2.3. Product benchmarking
    • 5.4.2.4. Strategic initiatives
  • 5.4.3. Carex
    • 5.4.3.1. Company overview
    • 5.4.3.2. Financial performance
    • 5.4.3.3. Product benchmarking
    • 5.4.3.4. Strategic initiatives
  • 5.4.4. Kaye Products, Inc.
    • 5.4.4.1. Company overview
    • 5.4.4.2. Financial performance
    • 5.4.4.3. Product benchmarking
    • 5.4.4.4. Strategic initiatives
  • 5.4.5. Briggs Healthcare
    • 5.4.5.1. Company overview
    • 5.4.5.2. Financial performance
    • 5.4.5.3. Product benchmarking
    • 5.4.5.4. Strategic initiatives
  • 5.4.6. Medline Industries, LP.
    • 5.4.6.1. Company overview
    • 5.4.6.2. Financial performance
    • 5.4.6.3. Product benchmarking
    • 5.4.6.4. Strategic initiatives
  • 5.4.7. NOVA
    • 5.4.7.1. Company overview
    • 5.4.7.2. Financial performance
    • 5.4.7.3. Product benchmarking
    • 5.4.7.4. Strategic initiatives
  • 5.4.8. Performance Health
    • 5.4.8.1. Company overview
    • 5.4.8.2. Financial performance
    • 5.4.8.3. Product benchmarking
    • 5.4.8.4. Strategic initiatives